BioCorRx Net Debt Growth & History (BICX)

BioCorRx's net debt was $19,767 for fiscal 2025.

View full BioCorRx company overview

BioCorRx annual net debt history

BioCorRx annual net debt

Fiscal yearPeriod endedNet debtChangeGrowth
20252025-12-31$19,767−$91,384−82.22%
20242024-12-31$111,151$42,696+62.37%
20232023-12-31$68,455−$44,258−39.27%
20222022-12-31$112,713−$248,561−68.80%
20212021-12-31$361,274$517,922
20202020-12-31−$156,648$2.1M
20192019-12-31−$2.2M−$5.4M
20182018-12-31$3.2M
20162016-12-31−$5,422−$1.6M
20152015-12-31$1.6M$920,238+128.31%
20142014-12-31$717,203−$300,273−29.51%
20132013-12-31$1.0M

BioCorRx net debt trends

Over the last five fiscal years, BioCorRx's net debt increased from −$156,648 to $19,767, a change of $176,415. The latest reported quarter, Q2 2026, shows $116,632.

About the metric

What net debt means

Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.

Calculation and source

How net debt is calculated

TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review BioCorRx source filings ↗

Community posts

It’s quiet here.

No posts about BICX yet. Start the conversation.

Write the first post